D. Western Therapeutics Institute, Inc. 6DW.F Stock
D. Western Therapeutics Institute, Inc. Price Chart
D. Western Therapeutics Institute, Inc. 6DW.F Financial and Trading Overview
Contents
| D. Western Therapeutics Institute, Inc. stock price | 0.43 EUR |
| Previous Close | 1.24 EUR |
| Open | 1.25 EUR |
| Bid | 1.24 EUR x 10000 |
| Ask | 1.45 EUR x 10000 |
| Day's Range | 1.25 - 1.25 EUR |
| 52 Week Range | 1.24 - 2.4 EUR |
| Volume | 300 EUR |
| Avg. Volume | 5 EUR |
| Market Cap | 43.91M EUR |
| Beta (5Y Monthly) | 0.478544 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.19 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6DW.F Valuation Measures
| Enterprise Value | -1359800576 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.102358975 |
| Price/Book (mrq) | 0.020916302 |
| Enterprise Value/Revenue | -3.17 |
| Enterprise Value/EBITDA | 4.213 |
Trading Information
D. Western Therapeutics Institute, Inc. Stock Price History
| Beta (5Y Monthly) | 0.478544 |
| 52-Week Change | -3.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.4 EUR |
| 52 Week Low | 1.24 EUR |
| 50-Day Moving Average | 1.31 EUR |
| 200-Day Moving Average | 1.63 EUR |
6DW.F Share Statistics
| Avg. Volume (3 month) | 5 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 31.69M |
| Float | 24.57M |
| Short Ratio | N/A |
| % Held by Insiders | 21.80% |
| % Held by Institutions | 3.74% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -117.71% |
| Operating Margin (ttm) | -86.013% |
| Gross Margin | 93.23% |
| EBITDA Margin | -75.23% |
Management Effectiveness
| Return on Assets (ttm) | -8.80% |
| Return on Equity (ttm) | -26.42% |
Income Statement
| Revenue (ttm) | 429M EUR |
| Revenue Per Share (ttm) | 14.26 EUR |
| Quarterly Revenue Growth (yoy) | -17.39% |
| Gross Profit (ttm) | 420M EUR |
| EBITDA | -322750016 EUR |
| Net Income Avi to Common (ttm) | -505000000 EUR |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.27B EUR |
| Total Cash Per Share (mrq) | 71.72 EUR |
| Total Debt (mrq) | 860M EUR |
| Total Debt/Equity (mrq) | 45.31 EUR |
| Current Ratio (mrq) | 16.215 |
| Book Value Per Share (mrq) | 59.762 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of D. Western Therapeutics Institute, Inc.
| Country | Germany |
| State | N/A |
| City | Nagoya |
| Address | CK21 Hirokoujifushimi Building |
| ZIP | 460-0003 |
| Phone | 81 5 2218 8785 |
| Website | https://www.dwti.co.jp |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on developing drugs to serve patients worldwide. The company offers GLANATEC, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM staining and peeling. It is also developing H-1337, a multikinase inhibitor that has completed Phase I/IIa clinical trials for the treatment of glaucoma/ocular hypertension; K-134, an antiplatelet agent, which has completed Phase IIb trials to treat arteriosclerosis obliterans; DW-1001, an ophthalmic treatment agent in nonclinical studies; and DW-5LBT, a lidocaine patch for neuropathic pain after shingles. The company was founded in 1999 and is headquartered in Nagoya, Japan.
Q&A For D. Western Therapeutics Institute, Inc. Stock
What is a current 6DW.F stock price?
D. Western Therapeutics Institute, Inc. 6DW.F stock price today per share is 0.43 EUR.
How to purchase D. Western Therapeutics Institute, Inc. stock?
You can buy 6DW.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for D. Western Therapeutics Institute, Inc.?
The stock symbol or ticker of D. Western Therapeutics Institute, Inc. is 6DW.F.
Which industry does the D. Western Therapeutics Institute, Inc. company belong to?
The D. Western Therapeutics Institute, Inc. industry is Biotechnology.
How many shares does D. Western Therapeutics Institute, Inc. have in circulation?
The max supply of D. Western Therapeutics Institute, Inc. shares is 39.85M.
What is D. Western Therapeutics Institute, Inc. Price to Earnings Ratio (PE Ratio)?
D. Western Therapeutics Institute, Inc. PE Ratio is now.
What was D. Western Therapeutics Institute, Inc. earnings per share over the trailing 12 months (TTM)?
D. Western Therapeutics Institute, Inc. EPS is -0.19 EUR over the trailing 12 months.
Which sector does the D. Western Therapeutics Institute, Inc. company belong to?
The D. Western Therapeutics Institute, Inc. sector is Healthcare.